PubRank

Tamio Teramoto

Author PubWeight™ 9.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. J Atheroscler Thromb 2013 1.42
2 Metabolic syndrome. J Atheroscler Thromb 2008 1.06
3 Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012. J Atheroscler Thromb 2013 0.88
4 Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.86
5 Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version. J Atheroscler Thromb 2013 0.83
6 Treatment - therapeutic lifestyle modification. J Atheroscler Thromb 2008 0.82
7 Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.82
8 Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version. J Atheroscler Thromb 2013 0.81
9 Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.78
10 Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb 2013 0.78
11 Metabolic syndrome. J Atheroscler Thromb 2013 0.76
12 Absolute risk of cardiovascular disease and lipid management targets. J Atheroscler Thromb 2013 0.75
13 Primary hyperlipidemia. J Atheroscler Thromb 2008 0.75
14 The elderly. J Atheroscler Thromb 2013 0.75
15 Chronic kidney disease. J Atheroscler Thromb 2013 0.75
16 Cerebrovascular diseases. J Atheroscler Thromb 2013 0.75
17 Statements. J Atheroscler Thromb 2014 0.75
18 Women. J Atheroscler Thromb 2008 0.75
19 Treatment--drug therapy. J Atheroscler Thromb 2008 0.75
20 Elderly patients. J Atheroscler Thromb 2008 0.75
21 Other high-risk conditions. J Atheroscler Thromb 2013 0.75